Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 419

1.

COVID-19 in the Eastern Mediterranean Region and Saudi Arabia: Prevention and Therapeutic Strategies.

Al-Tawfiq JA, Memish ZA.

Int J Antimicrob Agents. 2020 Apr 4:105968. doi: 10.1016/j.ijantimicag.2020.105968. [Epub ahead of print] No abstract available.

PMID:
32259576
2.

No time for dilemma: mass gatherings must be suspended.

Memish ZA, Ahmed QA, Schlagenhauf P, Doumbia S, Khan A.

Lancet. 2020 Mar 30. pii: S0140-6736(20)30754-6. doi: 10.1016/S0140-6736(20)30754-6. [Epub ahead of print] No abstract available.

PMID:
32240624
3.

Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19).

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A.

Crit Care Med. 2020 Mar 27. doi: 10.1097/CCM.0000000000004363. [Epub ahead of print]

PMID:
32224769
4.

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A.

Intensive Care Med. 2020 Mar 28. doi: 10.1007/s00134-020-06022-5. [Epub ahead of print]

5.

Covid-19 and community mitigation strategies in a pandemic.

Ebrahim SH, Ahmed QA, Gozzer E, Schlagenhauf P, Memish ZA.

BMJ. 2020 Mar 17;368:m1066. doi: 10.1136/bmj.m1066. No abstract available.

PMID:
32184233
6.

The cancellation of mass gatherings (MGs)? Decision making in the time of COVID-19.

Ahmed QA, Memish ZA.

Travel Med Infect Dis. 2020 Mar 14:101631. doi: 10.1016/j.tmaid.2020.101631. [Epub ahead of print]

7.

COVID-19 in the Shadows of MERS-CoV in the Kingdom of Saudi Arabia.

Barry M, Al Amri M, Memish ZA.

J Epidemiol Glob Health. 2020 Mar;10(1):1-3. doi: 10.2991/jegh.k.200218.003.

PMID:
32175703
8.

COVID-19 - the role of mass gatherings.

Ebrahim SH, Memish ZA.

Travel Med Infect Dis. 2020 Mar 9:101617. doi: 10.1016/j.tmaid.2020.101617. [Epub ahead of print]

9.

Transmission of respiratory tract infections at mass gathering events.

Petersen E, Memish ZA, Zumla A, Maani AA.

Curr Opin Pulm Med. 2020 May;26(3):197-202. doi: 10.1097/MCP.0000000000000675.

PMID:
32149751
10.

Diagnosis of SARS-CoV-2 Infection based on CT scan vs. RT-PCR: Reflecting on Experience from MERS-CoV.

Al-Tawfiq JA, Memish ZA.

J Hosp Infect. 2020 Mar 5. pii: S0195-6701(20)30100-6. doi: 10.1016/j.jhin.2020.03.001. [Epub ahead of print] No abstract available.

PMID:
32147407
11.

Remdesivir as a possible therapeutic option for the COVID-19.

Al-Tawfiq JA, Al-Homoud AH, Memish ZA.

Travel Med Infect Dis. 2020 Mar 5:101615. doi: 10.1016/j.tmaid.2020.101615. [Epub ahead of print] No abstract available.

PMID:
32145386
12.

Middle East respiratory syndrome.

Memish ZA, Perlman S, Van Kerkhove MD, Zumla A.

Lancet. 2020 Mar 28;395(10229):1063-1077. doi: 10.1016/S0140-6736(19)33221-0. Epub 2020 Mar 4. Review.

PMID:
32145185
13.

COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia.

Ebrahim SH, Memish ZA.

Lancet. 2020 Mar 14;395(10227):e48. doi: 10.1016/S0140-6736(20)30466-9. Epub 2020 Feb 27. No abstract available.

PMID:
32113506
14.

Saudi Arabia`s measures to curb the COVID-19 outbreak: temporary suspension of the Umrah pilgrimage.

Ebrahim SH, Memish ZA.

J Travel Med. 2020 Feb 28. pii: taaa029. doi: 10.1093/jtm/taaa029. [Epub ahead of print] No abstract available.

15.

Reducing mortality from 2019-nCoV: host-directed therapies should be an option.

Zumla A, Hui DS, Azhar EI, Memish ZA, Maeurer M.

Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5. No abstract available.

PMID:
32035018
16.

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.

Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E.

Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14. No abstract available.

17.

Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trial.

Arabi YM, Asiri AY, Assiri AM, Aziz Jokhdar HA, Alothman A, Balkhy HH, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Memish ZA, Ghazal S, Al Faraj S, Al-Hameed F, AlSaedi A, Mandourah Y, Al Mekhlafi GA, Sherbeeni NM, Elzein FE, Almotairi A, Al Bshabshe A, Kharaba A, Jose J, Al Harthy A, Al Sulaiman M, Mady A, Fowler RA, Hayden FG, Al-Dawood A, Abdelzaher M, Bajhmom W, Hussein MA; and the Saudi Critical Care Trials group.

Trials. 2020 Jan 3;21(1):8. doi: 10.1186/s13063-019-3846-x.

18.

MERS-CoV as an emerging respiratory illness: A review of prevention methods.

Baharoon S, Memish ZA.

Travel Med Infect Dis. 2019 Nov 12:101520. doi: 10.1016/j.tmaid.2019.101520. [Epub ahead of print] Review.

19.

The Middle East Respiratory Syndrome (MERS).

Azhar EI, Hui DSC, Memish ZA, Drosten C, Zumla A.

Infect Dis Clin North Am. 2019 Dec;33(4):891-905. doi: 10.1016/j.idc.2019.08.001. Review.

20.

Vaccine against Middle East respiratory syndrome coronavirus.

Zumla A, Memish ZA, Hui DS, Perlman S.

Lancet Infect Dis. 2019 Oct;19(10):1054-1055. doi: 10.1016/S1473-3099(19)30477-3. No abstract available.

PMID:
31559955
21.

The Hajj 2019 Vaccine Requirements and Possible New Challenges.

Al-Tawfiq JA, Memish ZA.

J Epidemiol Glob Health. 2019 Sep;9(3):147-152. doi: 10.2991/jegh.k.190705.001.

PMID:
31529930
22.

Risk of antibiotic resistant meningococcal infections in Hajj pilgrims.

Zumla A, Memish ZA.

BMJ. 2019 Aug 23;366:l5260. doi: 10.1136/bmj.l5260. No abstract available.

PMID:
31444169
23.

Modelling the importation risk of measles during the Hajj.

Massad E, Wilder-Smith AB, Wilder-Smith A, Memish ZA.

Lancet Infect Dis. 2019 Aug;19(8):806. doi: 10.1016/S1473-3099(19)30356-1. No abstract available.

PMID:
31345448
24.

Yellow fever and Hajj 2019: from airline introduction of mosquitoes to expanding geography of transmission and vaccination challenges.

Ebrahim SH, Memish ZA.

J Travel Med. 2019 Sep 2;26(6). pii: taz051. doi: 10.1093/jtm/taz051. No abstract available.

PMID:
31321432
25.

"Healthy Hajj 2019" -- what you need to know, before you go.

Ebrahim SH, Doumbia S, Elachola H, Memish ZA.

Travel Med Infect Dis. 2019 Jul - Aug;30:1-3. doi: 10.1016/j.tmaid.2019.07.006. Epub 2019 Jul 11. No abstract available.

PMID:
31302226
26.

Confronting the persisting threat of the Middle East respiratory syndrome to global health security.

Perlman S, Azhar EI, Memish ZA, Hui DS, Zumla A.

Lancet Infect Dis. 2020 Feb;20(2):158-160. doi: 10.1016/S1473-3099(19)30347-0. Epub 2019 Jul 3. No abstract available.

PMID:
31279728
27.

Measles and the 2019 Hajj: the risk of magnifying the global measles surge.

Memish ZA, Khan AA, Ebrahim S.

J Travel Med. 2019 Sep 2;26(6). pii: taz041. doi: 10.1093/jtm/taz041. No abstract available.

PMID:
31150094
28.

Middle East respiratory syndrome coronavirus in the last two years: Health care workers still at risk.

Al-Tawfiq JA, Memish ZA.

Am J Infect Control. 2019 Oct;47(10):1167-1170. doi: 10.1016/j.ajic.2019.04.007. Epub 2019 May 23.

29.

Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.

Memish ZA, Steffen R, White P, Dar O, Azhar EI, Sharma A, Zumla A.

Lancet. 2019 May 18;393(10185):2073-2084. doi: 10.1016/S0140-6736(19)30501-X. Review.

PMID:
31106753
30.

Meningitis vaccine shortage and the 2019 Hajj mass gathering: market dynamics and epidemic control.

Ebrahim SH, Assiri AM, Memish ZA.

J Travel Med. 2019 Jun 11;26(5). pii: taz039. doi: 10.1093/jtm/taz039. No abstract available.

PMID:
31094426
31.

Native valve Staphylococcus capitis infective endocarditis: a mini review.

Al Hennawi HET, Mahdi EM, Memish ZA.

Infection. 2020 Feb;48(1):3-5. doi: 10.1007/s15010-019-01311-8. Epub 2019 May 11. Review.

PMID:
31079347
32.

Hajj abattoirs in Makkah: risk of zoonotic infections among occupational workers.

Almasri M, Ahmed QA, Turkestani A, Memish ZA.

Vet Med Sci. 2019 Aug;5(3):428-434. doi: 10.1002/vms3.169. Epub 2019 Apr 23.

33.

A viral metagenomic survey identifies known and novel mammalian viruses in bats from Saudi Arabia.

Mishra N, Fagbo SF, Alagaili AN, Nitido A, Williams SH, Ng J, Lee B, Durosinlorun A, Garcia JA, Jain K, Kapoor V, Epstein JH, Briese T, Memish ZA, Olival KJ, Lipkin WI.

PLoS One. 2019 Apr 10;14(4):e0214227. doi: 10.1371/journal.pone.0214227. eCollection 2019.

34.

The Phoenix Arises Again: The 8th-year Celebration of the Journal of Epidemiology and Global Health (JEGH).

Shadeed S, Memish ZA.

J Epidemiol Glob Health. 2019 Mar;9(1):1-2. doi: 10.2991/jegh.k.190318.001. No abstract available.

PMID:
30932382
35.

Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study.

Alfaraj SH, Al-Tawfiq JA, Assiri AY, Alzahrani NA, Alanazi AA, Memish ZA.

Travel Med Infect Dis. 2019 May - Jun;29:48-50. doi: 10.1016/j.tmaid.2019.03.004. Epub 2019 Mar 11.

36.

Call to action for improved case definition and contact tracing for MERS-CoV.

Memish ZA.

J Travel Med. 2019 Jun 11;26(5). pii: taz001. doi: 10.1093/jtm/taz001. No abstract available.

37.
38.

Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review.

Benkouiten S, Al-Tawfiq JA, Memish ZA, Albarrak A, Gautret P.

Travel Med Infect Dis. 2019 Mar - Apr;28:15-26. doi: 10.1016/j.tmaid.2018.12.002. Epub 2018 Dec 4.

39.

MERS coronavirus outbreak: Implications for emerging viral infections.

Al-Omari A, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA.

Diagn Microbiol Infect Dis. 2019 Mar;93(3):265-285. doi: 10.1016/j.diagmicrobio.2018.10.011. Epub 2018 Oct 18. Review.

PMID:
30413355
40.

Middle East respiratory syndrome coronavirus intermittent positive cases: Implications for infection control.

Alfaraj SH, Al-Tawfiq JA, Memish ZA.

Am J Infect Control. 2019 Mar;47(3):290-293. doi: 10.1016/j.ajic.2018.08.020. Epub 2018 Oct 21.

41.

Impact of the Hajj on pneumococcal carriage and the effect of various pneumococcal vaccines.

Edouard S, Al-Tawfiq JA, Memish ZA, Yezli S, Gautret P.

Vaccine. 2018 Nov 19;36(48):7415-7422. doi: 10.1016/j.vaccine.2018.09.017. Epub 2018 Sep 17.

PMID:
30236632
42.

Lack of seasonal variation of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Al-Tawfiq JA, Memish ZA.

Travel Med Infect Dis. 2019 Jan - Feb;27:125-126. doi: 10.1016/j.tmaid.2018.09.002. Epub 2018 Sep 13. No abstract available.

PMID:
30218713
43.

MERS: What is the current situation in Saudi Arabia?

Memish ZA.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay065. No abstract available.

44.

Polio priority countries and the 2018 Hajj: Leveraging an opportunity.

Elachola H, Chitale RA, Ebrahim SH, Wassilak SGF, Memish ZA.

Travel Med Infect Dis. 2018 Sep - Oct;25:3-5. doi: 10.1016/j.tmaid.2018.08.003. Epub 2018 Aug 7. No abstract available.

PMID:
30096355
45.

Health of the Hajj.

Memish ZA.

Science. 2018 Aug 10;361(6402):533. doi: 10.1126/science.aau9617. Epub 2018 Aug 9. No abstract available.

PMID:
30093577
46.

From Hajj services to Mass Gathering Medicine: Saudi Arabia formalizes a novel discipline.

Ahmed QA, Ebrahim S, Memish ZA.

Travel Med Infect Dis. 2019 Mar - Apr;28:105-106. doi: 10.1016/j.tmaid.2018.07.007. Epub 2018 Jul 18. No abstract available.

PMID:
30012471
47.

Implications of converging conflicts, emergencies, and mass gatherings for global health security.

Elachola H, Doumbia S, Kattan RF, Abubakar I, Memish ZA.

Lancet Glob Health. 2018 Aug;6(8):e834-e835. doi: 10.1016/S2214-109X(18)30256-0. No abstract available.

48.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature.

Alfaraj SH, Al-Tawfiq JA, Memish ZA.

J Microbiol Immunol Infect. 2019 Jun;52(3):501-503. doi: 10.1016/j.jmii.2018.04.005. Epub 2018 Jun 2. Review. No abstract available.

49.

From the "Madding Crowd" to mass gatherings-religion, sport, culture and public health.

Ahmed QA, Memish ZA.

Travel Med Infect Dis. 2019 Mar - Apr;28:91-97. doi: 10.1016/j.tmaid.2018.06.001. Epub 2018 Jun 4. Review.

50.

Launching a Global Network of Virologists: The World Society for Virology (WSV).

Abdel-Moneim AS, Varma A, Pujol FH, Lewis GK, Paweska JT, Romalde JL, Söderlund-Venermo M, Moore MD, Nevels MM, Vakharia VN, Joshi V, Malik YS, Shi Z, Memish ZA.

Intervirology. 2017;60(6):276-277. doi: 10.1159/000488762. Epub 2018 Jun 6. No abstract available.

Supplemental Content

Loading ...
Support Center